会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Method of transdermally administering high molecular weight drugs with a
polymer skin enhancer
    • 用高分子皮肤增强剂透皮给药高分子量药物的方法
    • US6024975A
    • 2000-02-15
    • US745496
    • 1996-11-12
    • Joseph P. D'AngeloHenry Schur
    • Joseph P. D'AngeloHenry Schur
    • A61K9/70A61M37/00A61F13/00
    • A61K9/703A61K9/7092A61M2037/0007A61M37/0092Y10S514/944Y10S514/946
    • A high molecular weight drug is transdermally administered by applying a polymer skin enhancer and a drug active to the skin of the patient. The drug active has a molecular weight of above 50 daltons and takes at least 15% by weight of the system. The drug may be encapsulated or the drug solution may be partly encapsulated and partly free. The skin enhancer is polyvinylpyrrolidone (PVP) and it is mixed at between 7 and 35% of the drug. A gelling agent may be optionally added at up to 20% by volume. The chemical system is preferably administered via a multidose transdermal drug patch assembly which includes a drug-impervious support impressed to form a series of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The support is adhesively secured to the skin of a patient. Individual devices are provided for resealably enclosing the drug active in each of the reservoirs. The individual enclosing devices are removable to release the unit dose into contact with the skin of the patient and are actuable to control the transdermal absorption of the drug actives. The drug may also be administered in a creme.
    • 通过将聚合物皮肤增强剂和药物活性剂施用于患者的皮肤来透皮施用高分子量药物。 药物活性物质的分子量高于50道尔顿,至少占系统重量的15%。 药物可以被包封或药物溶液可以被部分包封并且部分游离。 皮肤增强剂是聚乙烯吡咯烷酮(PVP),并且在药物的7至35%之间混合。 可以任选地以高达20体积%添加胶凝剂。 化学系统优选经由多剂量透皮药物贴剂组合物施用,该药物贴剂组合物包括被压入以形成一系列隔室的药物不渗透性支持物。 每个隔室是用于经皮给药的药物活性单位剂量的储存器。 支撑体粘合地固定在患者的皮肤上。 提供单个装置用于可重新密封地包围每个储存器中的活性物质。 单独的包封装置是可移除的,以释放单位剂量与患者的皮肤接触,并且可致动以控制药物活性物质的透皮吸收。 药物也可以在奶油中施用。
    • 4. 发明授权
    • Method of transdermally administering high molecular weight drugs with a
polymer skin enhancer
    • 用高分子皮肤增强剂透皮给药高分子量药物的方法
    • US5614212A
    • 1997-03-25
    • US139316
    • 1993-10-19
    • Joseph P. D'AngeloHenry Schur
    • Joseph P. D'AngeloHenry Schur
    • A61K9/70A61M37/00A61F13/00
    • A61K9/703A61K9/7084A61K9/7092A61M2037/0007A61M37/0092Y10S514/946
    • A high molecular weight drug is transdermally administered by applying a polymer skin enhancer and a drug active to the skin of the patient. The drug active has a molecular weight of above 500 daltons. The drug may be encapsulated or the drug solution may be partly encapsulated and partly free. The skin enhancer is preferably polyvinylpyrrolidone (PVP) and it is mixed at between 7 and 35% of the drug. A gelling agent may be optionally added at up to 20% by volume. The chemical system is preferably administered via a multidose transdermal drug patch assembly which includes a drug-impervious support impressed to form a series of compartments. Each compartment is a reservoir for a unit dose of a drug active to be transdermally administered. The support is adhesively secured to the skin of a patient. Individual devices are provided for resealably enclosing the drug active in each of the reservoirs. The individual enclosing devices are removable to release the unit dose into contact with the skin of the patient and are actuable to control the transdermal absorption of the drug actives. The drug may also be administered in a creme.
    • 通过将聚合物皮肤增强剂和药物活性剂施用于患者的皮肤来透皮施用高分子量药物。 药物活性物质的分子量高于500道尔顿。 药物可以被包封或药物溶液可以被部分包封并且部分游离。 皮肤增强剂优选为聚乙烯吡咯烷酮(PVP),并且其在药物的7至35%之间混合。 可以任选地以高达20体积%添加胶凝剂。 化学系统优选经由多剂量透皮药物贴剂组合物施用,该药物贴剂组合物包括被压入以形成一系列隔室的药物不渗透性支持物。 每个隔室是用于经皮给药的药物活性单位剂量的储存器。 支撑体粘合地固定在患者的皮肤上。 提供单个装置用于可重新密封地包围每个储存器中的活性物质。 单独的包封装置是可移除的,以释放单位剂量与患者的皮肤接触,并且可致动以控制药物活性物质的透皮吸收。 药物也可以在奶油中施用。
    • 8. 发明授权
    • Saliva collector with an aspirating pipette
    • 唾液收集器与抽吸移液器
    • US5910122A
    • 1999-06-08
    • US869098
    • 1997-06-04
    • Joseph P. D'Angelo
    • Joseph P. D'Angelo
    • A61B10/00A61B5/00
    • A61B10/0051A61B2010/0009
    • Saliva samples are collected for body fluid constituent analysis by placing a sponge member into a patient's oral cavity. The sponge member is formed similarly to a pacifier nipple. Saliva is absorbed. The saliva is then expelled from the sponge member into a pipette. A filter may be placed between the sponge member and the pipette, through which the saliva is cleaned and molecular weight-selectively prepared by letting only substances through with a molecular weight below a cut-off weight. The integral unit is dismembered after the saliva has been transferred into the collection pipette, and the latter is tightly closed off for further handling.
    • 通过将海绵构件放入患者的口腔中来收集唾液样品用于体液成分分析。 海绵构件类似于安抚奶嘴形成。 唾液被吸收。 然后将唾液从海绵部件排出成移液管。 过滤器可以放置在海绵构件和移液管之间,唾液被清洁,并且通过仅使物质通过分子量低于截止重量来分子量选择性地制备。 在唾液已经转移到收集移液管中后,整体单元被分解,后者紧密关闭以进一步处理。